Using AI-driven models to predict metabolic instabilities in different diseases, ScandiBio develops therapies targeting metabolic and mitochondrial dysfunction.
Investors 1
Date | Name | Website |
- | Navigare V... | navigareve... |
Date | Name | Website |
- | Navigare V... | navigareve... |